Medical Eye Care
Thyroid Eye Disease Management
Vision & Precision
OVERVIEW
Thyroid Eye Disease (TED), also known as Graves' ophthalmopathy, is an inflammatory condition that causes the muscles and fat behind the eye to expand, pushing the eye forward (proptosis) and causing eyelid retraction, double vision, and in severe cases, vision loss. Dr. Gordon provides comprehensive management — from medical therapy during the active phase to surgical rehabilitation once the disease stabilizes.
BENEFITS
Expert monitoring to detect and prevent vision-threatening complications
Medical management to suppress active orbital inflammation
Surgical decompression to relieve pressure on the optic nerve
Strabismus surgery to correct persistent double vision
Eyelid surgery to address retraction and exposure
AM I A CANDIDATE?
- Patients with a known or suspected thyroid disorder who develop eye symptoms — including eye protrusion, double vision, light sensitivity, eyelid swelling, or difficulty closing the eyes — should seek prompt evaluation. Close collaboration between Dr. Gordon and an endocrinologist ensures optimal management of both the thyroid disease and its ocular manifestations.
THE PROCEDURE
In the active inflammatory phase, treatment may include systemic steroids, radiation therapy, or Teprotumumab (Tepezza), the first FDA-approved treatment specifically for TED. Once the disease has been inactive for at least six months, rehabilitative surgery is performed in a staged sequence: orbital decompression first, followed by strabismus surgery if needed, and then eyelid surgery as the final step.
READY TO GET STARTED?
Schedule your personalized consultation with Dr. Gordon and take the first step toward your treatment goals.